Chemoinformaics analysis of 2-(5-METHYL-2-PROPAN-2-YLCYCLOHEXYL)-4-PROP-2-ENYLPHENOL
Molecular Weight | 272.432 | nRot | 4 |
Heavy Atom Molecular Weight | 244.208 | nRig | 13 |
Exact Molecular Weight | 272.214 | nRing | 2 |
Solubility: LogS | -6.327 | nHRing | 0 |
Solubility: LogP | 5.718 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 19 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 1 | APOL | 51.2022 |
nHD | 1 | BPOL | 28.0898 |
QED | 0.738 |
Synth | 3.495 |
Natural Product Likeliness | 1.288 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.183 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.472 |
MDCK | 0.0000178 |
BBB | 0.387 |
PPB | 0.994994 |
VDSS | 1.818 |
FU | 0.00842038 |
CYP1A2-inh | 0.343 |
CYP1A2-sub | 0.769 |
CYP2c19-inh | 0.83 |
CYP2c19-sub | 0.895 |
CYP2c9-inh | 0.549 |
CYP2c9-sub | 0.968 |
CYP2d6-inh | 0.255 |
CYP2d6-sub | 0.891 |
CYP3a4-inh | 0.545 |
CYP3a4-sub | 0.645 |
CL | 12.933 |
T12 | 0.137 |
hERG | 0.023 |
Ames | 0.033 |
ROA | 0.112 |
SkinSen | 0.657 |
Carcinogencity | 0.163 |
EI | 0.556 |
Respiratory | 0.24 |
NR-Aromatase | 0.01 |
Antiviral | No |
Prediction | 0.657269 |